• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院感染的克里米亚-刚果出血热疫情。

Nosocomial outbreak of Crimean-Congo haemorrhagic fever.

机构信息

Department of Infectious Diseases, Imam Reza General Hospital, School of Medicine, Mashhad University of Medical Sciences, Iran.

出版信息

Epidemiol Infect. 2011 Jun;139(6):862-6. doi: 10.1017/S0950268810002001. Epub 2010 Aug 27.

DOI:10.1017/S0950268810002001
PMID:20800007
Abstract

We report a nosocomial outbreak of Crimean-Congo haemorrhagic fever (CCHF) that affected six patients in June 2009 in Ghaem Hospital, Mashhad, Iran, apparently related to one index case. The last four cases were healthcare workers. Infection was spread by percutaneous exposure to two cases, and probably by direct contact with blood, clothes and sheets, to three others. The diagnosis in the two fatal cases was not confirmed virologically. The diagnosis in four cases who survived was confirmed by specific reverse transcription polymerase chain reaction. The patients were treated with ribavirin. In endemic areas, every patient presenting with a febrile haemorrhagic syndrome should be considered to have a viral haemorrhagic fever until proven otherwise. Patients who meet the criteria for probable CCHF should be admitted to hospital and treated with ribavirin. Appropriate isolation precautions should be immediately initiated.

摘要

我们报告了一起 2009 年 6 月在伊朗马什哈德 Ghaem 医院发生的克里米亚-刚果出血热(CCHF)医院感染暴发事件,该起事件显然与 1 例指数病例有关。最后 4 例为医护人员。感染通过 2 例经皮暴露传播,另外 3 例可能通过直接接触血液、衣服和床单传播。2 例死亡病例的诊断未通过病毒学确认。4 例存活病例的诊断通过特异性逆转录聚合酶链反应确认。这些患者接受了利巴韦林治疗。在流行地区,凡出现发热性出血综合征的患者,在排除其他情况之前,均应视为患有病毒性出血热。符合可能的 CCHF 标准的患者应住院并接受利巴韦林治疗。应立即采取适当的隔离预防措施。

相似文献

1
Nosocomial outbreak of Crimean-Congo haemorrhagic fever.医院感染的克里米亚-刚果出血热疫情。
Epidemiol Infect. 2011 Jun;139(6):862-6. doi: 10.1017/S0950268810002001. Epub 2010 Aug 27.
2
Nosocomial infection of Crimean-Congo haemorrhagic fever in eastern Iran: case report.伊朗东部发生克里米亚-刚果出血热医院感染:病例报告。
Travel Med Infect Dis. 2013 Jul-Aug;11(4):252-5. doi: 10.1016/j.tmaid.2012.11.009. Epub 2012 Dec 21.
3
Short report: Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002.简短报告:2002年2月巴基斯坦拉瓦尔品第发生克里米亚-刚果出血热疫情。
Am J Trop Med Hyg. 2003 Sep;69(3):284-7.
4
The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.口服利巴韦林治疗伊朗克里米亚-刚果出血热的疗效
Clin Infect Dis. 2003 Jun 15;36(12):1613-8. doi: 10.1086/375058. Epub 2003 Jun 4.
5
The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study.伊朗东南部扎黑丹的克里米亚-刚果出血热患者的治疗结果:一项对比研究。
Arch Iran Med. 2009 Mar;12(2):151-3.
6
Crimean Congo haemorrhagic fever, precautions and ribavirin prophylaxis: a case report.克里米亚-刚果出血热、预防措施及利巴韦林预防:一例报告
Scand J Infect Dis. 2009;41(5):378-80. doi: 10.1080/00365540902882434.
7
Crimean-Congo hemorrhagic fever.克里米亚-刚果出血热
Curr Opin Infect Dis. 2007 Oct;20(5):495-500. doi: 10.1097/QCO.0b013e3282a56a0a.
8
Erythema nodosum in the course of Crimean-Congo haemorrhagic fever.克里米亚-刚果出血热病程中的结节性红斑
Trop Doct. 2010 Apr;40(2):123-4. doi: 10.1258/td.2009.090359.
9
Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran.克里米亚-刚果出血热病毒作为伊朗医院内的病原体
Am J Trop Med Hyg. 2009 Oct;81(4):675-8. doi: 10.4269/ajtmh.2009.09-0051.
10
Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study.利巴韦林治疗对克里米亚-刚果出血热患者生存率的疗效评估:一项病例对照研究。
Jpn J Infect Dis. 2009 Jan;62(1):11-5.

引用本文的文献

1
Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virus.复制子颗粒疫苗接种诱导非中和性抗核蛋白抗体介导的克里米亚-刚果出血热病毒控制。
NPJ Vaccines. 2024 May 23;9(1):88. doi: 10.1038/s41541-024-00877-1.
2
Seroprevalence of Crimean Congo Hemorrhagic Fever Virus in Occupational Settings: Systematic Review and Meta-Analysis.职业环境中克里米亚-刚果出血热病毒的血清流行率:系统评价与荟萃分析
Trop Med Infect Dis. 2023 Sep 19;8(9):452. doi: 10.3390/tropicalmed8090452.
3
Multiplex Assay for Simultaneous Detection of Antibodies against Crimean-Congo Hemorrhagic Fever Virus Nucleocapsid Protein and Glycoproteins in Ruminants.
用于同时检测反刍动物中抗克里米亚-刚果出血热病毒核衣壳蛋白和糖蛋白抗体的多重检测法
Microbiol Spectr. 2023 Feb 23;11(2):e0260022. doi: 10.1128/spectrum.02600-22.
4
Monitoring Crimean-Congo haemorrhagic fever virus RNA shedding in body secretions and serological status in hospitalised patients, Turkey, 2015.监测 2015 年土耳其住院患者体液中克里米亚-刚果出血热病毒 RNA 脱落情况和血清学状态。
Euro Surveill. 2020 Mar;25(10). doi: 10.2807/1560-7917.ES.2020.25.10.1900284.
5
Emerging zoonotic viral infections of occupational health importance.新兴职业健康相关的人畜共患病毒性传染病。
Pathog Dis. 2019 Mar 1;77(2). doi: 10.1093/femspd/ftz018.
6
Crimean-Congo hemorrhagic fever and expansion from endemic regions.克里米亚-刚果出血热及其从流行地区的扩散。
Curr Opin Virol. 2019 Feb;34:70-78. doi: 10.1016/j.coviro.2018.12.002. Epub 2019 Jan 16.
7
Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers.系统评价和荟萃分析医护人员中克里米亚-刚果出血热病毒暴露后预防措施。
Emerg Infect Dis. 2018 Sep;24(9):1642-1648. doi: 10.3201/eid2409.171709.
8
Ribavirin for treating Crimean Congo haemorrhagic fever.利巴韦林治疗克里米亚-刚果出血热
Cochrane Database Syst Rev. 2018 Jun 5;6(6):CD012713. doi: 10.1002/14651858.CD012713.pub2.
9
Investigation of an isolated case of human Crimean-Congo hemorrhagic fever in Central Uganda, 2015.2015 年乌干达中部一起孤立的克里米亚-刚果出血热病例调查。
Int J Infect Dis. 2018 Mar;68:88-93. doi: 10.1016/j.ijid.2018.01.013. Epub 2018 Jan 31.
10
Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center cross-sectional survey in Eurasia.克里米亚-刚果出血热的感染预防与控制实践——一项在欧亚大陆开展的多中心横断面调查
PLoS One. 2017 Sep 8;12(9):e0182315. doi: 10.1371/journal.pone.0182315. eCollection 2017.